Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,398
Closed -$2.37M 3991
2025
Q4
$2.37M Sell
29,398
-45,051
-61% -$3.62M 0.01% 1202
2025
Q3
$6.11M Buy
74,449
+57,572
+341% +$4.99M 0.02% 592
2025
Q2
$1.54M Sell
16,877
-195,658
-92% -$17.5M 0.01% 1051
2025
Q1
$19.4M Buy
212,535
+186,856
+728% +$16.3M 0.12% 114
2024
Q4
$2.19M Buy
+25,679
New +$2.25M 0.01% 703
2023
Q4
Sell
-44,378
Closed -$3.75M 2467
2023
Q3
$3.75M Sell
44,378
-43,538
-50% -$3.93M 0.04% 391
2023
Q2
$8.69M Buy
87,916
+18,083
+26% +$1.7M 0.08% 172
2023
Q1
$6.71M Buy
69,833
+5,775
+9% +$534K 0.08% 195
2022
Q4
$5.82M Sell
64,058
-11,306
-15% -$962K 0.08% 223
2022
Q3
$5.99M Sell
75,364
-10,944
-13% -$927K 0.06% 243
2022
Q2
$7.19M Buy
86,308
+7,460
+9% +$615K 0.08% 183
2022
Q1
$6.48M Buy
78,848
+69,839
+775% +$5.47M 0.05% 224
2021
Q4
$674K Buy
+9,009
New +$676K ﹤0.01% 1528
2021
Q3
Sell
-53,902
Closed -$4.17M 3389
2021
Q2
$4.17M Buy
53,902
+47,129
+696% +$3.64M 0.04% 353
2021
Q1
$475K Buy
6,773
+1,050
+18% +$79.3K ﹤0.01% 1832
2020
Q4
$405K Buy
5,723
+241
+4% +$15.1K 0.01% 1134
2020
Q3
$314K Sell
5,482
-2,843
-34% -$170K 0.01% 1112
2020
Q2
$506K Buy
+8,325
New +$514K 0.02% 774

Other funds holding DOX

HRT Financial's DOX Position: Q1 2026 in Review

HRT Financial sold out of Amdocs (DOX) in Q1 2026, closing a stake of 29,398 shares — an estimated $2.37M sold.

HRT Financial first reported a position in DOX in Q2 2020 and held it in 18 quarters. The position peaked at $19.4M in Q1 2025. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • HRT Financial reported no remaining Amdocs position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 29,398 Amdocs shares in Q1 2026, an estimated $2.37M.
  • HRT Financial first reported a position in Amdocs in Q2 2020 and held it in 18 quarters.
  • HRT Financial's Amdocs position peaked at $19.4M in Q1 2025.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.